GLPcompare · House #30,156

What it is

Calls itself “informational data platform”.

• Calls itself: informational data platform

“GLPcompare is an informational data platform, not a medical provider or pharmacy.”

Where it puts itself

Claims “fully-cited reference”. Publishes a comparison page.

• Superlative claim: fully-cited reference

“GLPcompare The live, fully-cited reference for the GLP-1 ecosystem.”

“Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment.”

What it costs

Monthly subscription. 6 prices listed on its pages, from $149 to $449.

• Monthly: yes
• Commission: no
• Price: 6 prices, from $149 to $449

“Prices from $149-$299/mo Self-pay cash prices, manufacturer to compounded, plus NADAC acquisition cost.”

“At trial dose $299/mo ( Self-Pay Journey price for 14.5 mg and 17.2 mg with a refill within 45 days; regular price $349. Eligibility, additional taxes and fees may apply. )”

Who it sells to

Sells to consumers.

• Sells to: consumers

“What is the cheapest FDA-approved GLP-1 without insurance?”

How it runs

A web app. Hosted in the cloud. AI is a side feature. Built with Google Analytics.

• Kind: web
• Runs where: cloud / hosted
• AI role: a side feature
• Analytics: Google Analytics

“Search with AI”

“GLPcompare is an informational data platform”

What it works with

Names Foundayo, Mounjaro and 5 more on its pages.

• Names: Foundayo · Mounjaro · Ozempic · +4

“Orforglipron Foundayo”

“GLPcompare is an informational data platform, not a medical provider or pharmacy.”

What it offers as proof

Live, no waitlist. Claims “15”. Publishes a blog.

• Number claimed: 15

“15 GLP-1 medications, shortage reports and sourced cash prices”

“News -> https://glpcompare.co/news”